New and treatment-relevant risk stratification for thrombosis in essential thrombocythemia and polycythemia vera
The role of bone marrow biopsy and FDG-PET/CT in identifying bone marrow infiltration in the initial diagnosis of high grade non-Hodgkin B-cell lymphoma and Hodgkin lymphoma. accuracy in a multicenter series of 372 patients
Alloimmunization is associated with older age of transfused red blood cells in sickle cell disease
Survival outcomes of secondary cancers in patients with waldenström macroglobulinemia: An analysis of the SEER database
Immune status of patients with inherited bone marrow failure syndromes
Depression and cognitive impairment following recovery from thrombotic thrombocytopenic purpura
Inferior outcome after allogeneic transplant in first remission in high-risk AML patients who required more than two cycles of induction therapy
Outcome of conditioning intensity in acute myeloid leukemia with monosomal karyotype in patients over 45 year-old: A study from the acute leukemia working party (ALWP) of the European group of blood and marrow transplantation (EBMT)
Hypercoagulability in adolescent girls on oral contraceptives-global coagulation profile and estrogen receptor polymorphisms
Characteristics, clinical outcome, and prognostic significance of IDH mutations in AML
Incidence of ATRX mutations in myelodysplastic syndromes, the value of microcytosis
Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management
ALK-positive anaplastic large cell lymphoma presenting with hemophagocytic lymphohistiocytosis
Non–injection-site necrotic skin lesions complicating postoperative heparin thromboprophylaxis
A “body armor” of leukemia cutis
Disseminated histoplasmosis as pseudo Richter's transformation in a patient with chronic lymphocytic leukemia
Evaluation of a multi-target direct thrombin inhibitor dosing and titration guideline for patients with suspected heparin-induced thrombocytopenia
The role of hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma
Immortal time bias and reverse causality in retrospective analysis: Comment on “effect of cumulative bortezomib dose on survival in multiple myeloma patients receiving bortezomib–melphalan–prednisone in the phase III VISTA study”
Authors’ Response
Myeloid sarcoma as the initial presentation of chronic myelogenous leukemia, medullary chronic phase in era of tyrosine kinase inhibitors: A report of 11 cases
Effectiveness of lenalidomide in a patient with refractory anemia with ring sideroblasts and thrombocytosis with JAK2 (V617F) mutation
Lessons from very severe, refractory, and fatal primary autoimmune hemolytic anemias
Biological characterization of stage I follicular lymphoma according to extranodal or nodal primary origin and t(14;18) status using high-resolution array-based comparative genomic hybridization
Successful treatment with Rituximab and Bendamustine in a patient with newly diagnosed Waldenström's Macroglobulinemia complicated by Bing-Neel syndrome
Erythropoietin receptor modulates breast cancer cell response to tamoxifen treatment
Study of erythropoietin receptor activation in living cells by Förster resonance energy transfer microscopy
Sensitive and Specific Probes for the Erythropoietin Receptor in Clinical Samples
Development and specificity testing of novel antibodies directed against the human erythropoietin receptor
New polyclonal and monoclonal antibodies against the human and murine EPO-receptor
Epicardial Erythropoietin release improves cardiac functions and enhances rapid proliferation and tissue transformation in the intracardiac mesenchyme after myocardial infarction.
Investigation of Erythropoietin, Tnf-α and Kidney Tissue Injury Connections in L-NAME Induced Hypertensive Rats
Erythropoietin and Metabolic Response
Bone Homeostasis is Regulated by the PHD2 - HIF2α - EPO Axis
EPO attenuation of bone formation: contribution of non-osteoblastic cells?
Erythropoietin in insects: receptors, signaling pathways and neuroprotection
Inducible formation of hippocampal oligodendrocytes from pre-existing local precursors by erythropoietin
Erythropoietin induces formation of hippocampal CA neurons from preexisting local precursors
Results of the Swiss Epo Neuroprotection Trial in Very Preterm Infants
Neural correlates of improved executive function following erythropoietin treatment in mood disorders
Cell-specific upregulation of the transcription factor ARNT (HIF-1β) in response to hypoxia
Destruction of a distal hypoxia response element abolishes trans-activation of the PAG1 gene mediated by HIF-independent chromatin looping
Hypoxic inhibition of JMJD3 reduces H3K27me3 demethylation, chromatin remodeling, and induction of the STAT6 target gene Ccl18
Regulation of protein expression under chronic hypoxia
Contrasting roles of HIF-1 and 2 in ventilatory acclimatisation to hypoxia
Semisynthesis of Two Glycoforms of Human Erythropoietin
The transcription factor ARNT influences radiation sensibility in different cell lines
Transcriptome partitioning for mRNA translation in hypoxia
Erythropoietin dampens injury-induced microglial motility
The importin α/β-specific inhibitor Ivermectin affects HIF-dependent hypoxia response pathways
The decrease of M-CSF expression in the brain endothelium by acute hyperglycemia leads to a reduction in tissue protective M2 macrophages after ischemic stroke.
Ectopic hyperplastic renin expressing cells can transform into erythropoietin expressing cells at any time.
Relationship between plasma activin A levels and excretory renal function
Cord Blood Erythropoietin Levels after Maternal Obesity During Gestation
Effect of rHuEPO therapy on long-term survival of children with acute lymphoblastic leukemia, undergoing chemotherapy according to the program ALL BFM-90m.
Multicentre, non-interventional study with epoetin theta in patients with chemotherapy-induced symptomatic anemia (EPO-amb) conducted in Germany
Angiogenic potential of hypoxic conditioned media from ovarian adenocarcinoma A2780 cells: the effect of erythropoietin
Effect of intermittent hypoxic training on erythropoietin level in relation to inflammatory response
Small RNA sequencing of red blood cell specific miRNAs reveals expression changes after 6 weeks of recombinant EPO (rEPO) administration in healthy recreational athletes.
First results on regenerative effects of erythropoietin in patients with burn and scald injures (clinical trial: “EPO in Burns”)
Co- and Posttranslational modification of Erythropoietin: new semi-synthetic approaches
Regulation of the EPO Gene
Distinct populations of FoxD1-derived peritubular interstitial cells regulate erythropoietin (EPO) production in the kidney.
Renal Erythropoietin Producing Cells for Anemia and Fibrosis
Inducible glomerular erythropoietin production in the adult kidney
Prolyl-4-hydroxylase 2 potentially contributes to hepatocellular carcinoma-associated erythrocytosis by maintaining hepatocyte nuclear factor-4α expression
EPO and EMT - new insights in EPO regulation
Clinical Experience with Roxadustat, a HIF-PHI, in the treatment of CKD associated anemia
Epoetin beta pegol retains its biological activity in the presence of the sialic acid metabolic enzyme sialidase
A non-hematopoietic erythropoietin variant expressed in human blood
The effect of inactivated VHL gene on proliferative pathways in renal cell carcinoma
Erythrocytic system under the influence of sports training - sports anemia, hypoxic training and blood doping
Phenotype and proliferation capacity of CD4+ T and B cells of patients with end-stage renal disease depending on treatment with recombinant human erythropoietin
Erythropoietin treatment is associated with improved immune parameters in patients with lower risk myelodsyplastic syndromes
Erythropoietin in 5T33 Murine Multiple Myeloma: Opposing Immune and Skeletal Outcomes
Erythropoietin: a burden or an asset?